The Rift Valley Fever virus protein NSm and putative cellular protein interactions

Virology Journal

Volumn 9, Issue , 2012, Pages

  Engdahl, Cecilia ^a   Näslund, Jonas ^a   Lindgren, Lena ^a   Ahlm, Clas ^a   Bucht, Göran ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

Cpsf2; NSm; Ppil2; Rift Valley fever; SNAP 25; Yeast two hybrid

Indexed keywords

CELL PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 2; COMPLEMENTARY DNA; EF HAND CALCIUM BINDING DOMAIN-CONTAINING PROTEIN 7; PEPTIDYLPROLYL ISOMERASE LIKE 2 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RING FINGER AND CHY ZINC FINGER DOMAIN CONTAINING PROTEIN 1; RNA BINDING PROTEIN EWS; SERINE ARGININE RICH SPLICING FACTOR 3; SUPPRESSION OF TUMORIGENICITY 13 PROTEION; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CEREAL; CONTROLLED STUDY; DNA LIBRARY; MOLECULAR CLONING; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RIFT VALLEY FEVER BUNYAVIRUS; SACCHAROMYCES CEREVISIAE; YEAST;

ANIMALS; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CYCLOPHILINS; HUMANS; MICE; PROTEIN BINDING; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA; MURINAE; RIFT VALLEY FEVER VIRUS;

EID: 84864201058     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-139     Document Type: Article

References (47)

1. Enzootic hepatitis of Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. Daubney R, Garnham P, J Pathol Bacteriol 1931 34 8922 8926
2. The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizzotic and virological studies. Meegan JM, Trans R Soc Trop Med Hyg 1979 73 618 623 10.1016/0035-9203(79)90004-X 538803
3. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, Al-Mazrou Y, Khan AS, Rollin PE, Swanepoel R, Ksiazek TG, Nichol ST, Emerg Infect Dis 2002 8 1415 1420 10.3201/eid0812.020195 12498657
4. The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs. Coetzer JA, Onderstepoort J Vet Res 1977 44 205 211 613292
5. The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses. Coetzer JA, Onderstepoort J Vet Res 1982 49 11 17 7122060
6. Epidemiological assessment of the Rift Valley fever outbreak in Kenya and Tanzania in 2006 and 2007. Jost CC, Nzietchueng S, Kihu S, Bett B, Njogu G, Swai ES, Mariner JC, AmJTrop Med Hyg 2010 83 65 72
7. Rift Valley fever outbreak in livestock in Kenya, 2006-2007. Munyua P, Murithi RM, Wainwright S, Githinji J, Hightower A, Mutonga D, Macharia J, Ithondeka PM, Musaa J, Breiman RF, et al. AmJTrop Med Hyg 2010 83 58 64
8. Rift Valley fever virus. Flick R, Bouloy M, Curr Mol Med 2005 5 827 834 10.2174/156652405774962263 16375716
9. Rift Valley fever. Gerdes GH, Rev Sci Tech 2004 23 613 623 15702723
10. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J, Vet Res 2010 41 61 10.1051/vetres/2010033 21188836
11. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish AA, Khan AS, Ksiazek TG, Shobokshi O, Clin Infect Dis 2003 37 1084 1092 10.1086/378747 14523773
12. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Mohamed M, Mosha F, Mghamba J, Zaki SR, Shieh WJ, Paweska J, Omulo S, Gikundi S, Mmbuji P, Bloland P, et al. AmJTrop Med Hyg 2010 83 22 27
13. Rift Valley fever-a threat for Europe? Chevalier V, Pépin M, Plée L, Lancelot R, Eur Surveill 2010 15 19506
14. Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Bouloy M, Flick R, Antivir Res 2009 84 101 118 10.1016/j.antiviral.2009.08.002 19682499
15. Rift valley fever vaccines. Ikegami T, Makino S, Vaccine 2009 27 Suppl 4 69 D72 19837291
16. Elliott RM, The Bunyaviridae Plenum Press, New York 1996
17. Swanepoel R, Burt FJ, Principles and Practice of Clinical Virology John Wiley & Sons Ltd, 6 2009
18. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O, J Virol 2004 78 9798 9806 10.1128/JVI.78.18.9798- 9806.2004 15331713
19. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O, J Virol 2001 75 1371 1377 10.1128/JVI.75.3.1371- 1377.2001 11152510
20. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S, Ann N Y Acad Sci 2009 1171 Suppl 1 75 E85 19751406
21. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM, Cell 2004 116 541 550 10.1016/S0092-8674(04)00132-1 14980221
22. Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. Mansuroglu Z, Josse T, Gilleron J, Billecocq A, Leger P, Bouloy M, Bonnefoy E, J Virol 2010 84 928 939 10.1128/JVI.01165-09 19889787
23. NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. Won S, Ikegami T, Peters CJ, Makino S, J Virol 2006 80 8274 8278 10.1128/JVI.00476-06 16873285
24. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Gerrard SR, Bird BH, Albarĩo CG, Nichol ST, Virology 2007 359 459 465 10.1016/j.virol.2006.09.035 17070883
25. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Bird BH, Albarĩo CG, Nichol ST, Virology 2007 362 10 15 10.1016/j.virol.2007.01. 046 17412386
26. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. Won S, Ikegami T, Peters CJ, Makino S, J Virol 2007 81 13335 13345 10.1128/JVI.01238-07 17913816
27. Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. Narayanan A, Popova T, Turell M, Kidd J, Chertow J, Popov SG, Bailey C, Kashanchi F, Kehn-Hall K, PLoS One 2011 6 20354 10.1371/journal.pone.0020354 21655261
28. SNARE assembly and disassembly exhibit a pronounced hysteresis. Fasshauer D, Antonin W, Subramaniam V, Jahn R, Nat Struct Biol 2002 9 144 151 10.1038/nsb750 11786917
29. Neurotransmitter release-four years of SNARE complexes. Hanson PI, Heuser JE, Jahn R, Curr Opin Neurobiol 1997 7 310 315 10.1016/S0959-4388(97)80057-8 9232812
30. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. Oyler GA, Higgins GA, Hart RA, Battenberg E, Billingsley M, Bloom FE, Wilson MC, J Cell Biol 1989 109 3039 3052 10.1083/jcb.109.6.3039 2592413
31. Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. Ravichandran V, Chawla A, Roche PA, J Biol Chem 1996 271 13300 13303 10.1074/jbc.271.23.13300 8663154
32. Kinetics of Rift Valley Fever Virus in experimentally infected mice using quantitative real-time RT-PCR. Näslund J, Lagerqvist N, Lundkvist A, Evander M, Ahlm C, Bucht G, J Virol Methods 2008 151 277 282 10.1016/j.jviromet.2008.04.007 18514921
33. The pathogenesis of Rift Valley fever virus in the mouse model. Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE, Virology 2010 407 256 267 10.1016/j.virol.2010.08.016 20850165
34. The Pathogenesis of Rift Valley Fever. Ikegami T, Makino S, Viruses 2011 3 493 519 10.3390/v3050493 21666766
35. Rift Valley fever encephalitis. Alrajhi AA, Al-Semari A, Al-Watban J, Emerg Infect Dis 2004 10 554 555 10.3201/eid1003.020817 15116716
36. Pathways for cytokine secretion. Stanley AC, Lacy P, Physiology (Bethesda) 2010 25 218 229 10.1152/physiol.00017.2010
37. Identification of a nuclear-specific cyclophilin which interacts with the proteinase inhibitor eglin c. Wang BB, Hayenga KJ, Payan DG, Fisher JM, Biochem J 1996 314 Pt 1 313 319 8660300
38. Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, Nakayama KI, Sherry B, Bukrinsky MI, J Biol Chem 2005 280 27866 27871 10.1074/jbc.M503770200 15946952
39. Immunophilins: for the love of proteins. Barik S, Cell Mol Life Sci 2006 63 2889 2900 10.1007/s00018-006-6215-3 17075696
40. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M, Clin Exp Immunol 2010 160 305 317 10.1111/j.1365-2249.2010.04115.x 20345978
41. Cyclophilins: unexpected messengers in intercellular communications. Bukrinsky MI, Trends Immunol 2002 23 323 325 10.1016/S1471-4906(02)02237-8 12103338
42. Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit. Jenny A, Hauri HP, Keller W, Mol Cell Biol 1994 14 8183 8190 7969155
43. A history of poly A sequences: from formation to factors to function. Edmonds M, Prog Nucleic Acid Res Mol Biol 2002 71 285 389 12102557
44. 3' end mRNA processing: molecular mechanisms and implications for health and disease. Danckwardt S, Hentze MW, Kulozik AE, EMBO J 2008 27 482 498 10.1038/sj.emboj.7601932 18256699
45. Genetic reassortment of Rift Valley fever virus in nature. Sall AA, Zanotto PM, Sene OK, Zeller HG, Digoutte JP, Thiongane Y, Bouloy M, J Virol 1999 73 8196 8200 10482570
46. A conserved alpha-helix essential for a type VI secretion-like system of Francisella tularensis. Bröms JE, Lavander M, Sjöstedt A, J Bacteriol 2009 191 2431 2446 10.1128/JB.01759-08 19201795
47. Miller JH, Experiments in Molecular Genetics Cold Spring Harbor Laboratory, New York 1972